Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Chambal Biotech Ltd
NSE: CHAMBALBIOBSE: 549886Pharma Formulations
₹603.25
▲ 13.05 (+2.21%)
Quarterly Results
- Jun '25: 8,258
- Sep '25: 8,373
- Dec '25: 8,734
- Mar '26: 9,633
- Jun '26: 9,558
- Jun '25: 1,355
- Sep '25: 1,374
- Dec '25: 1,433
- Mar '26: 1,581
- Jun '26: 1,672
- Jun '25: ₹5.44
- Sep '25: ₹5.52
- Dec '25: ₹5.76
- Mar '26: ₹6.35
- Jun '26: ₹6.72
| ₹ Cr | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue from operations | 8,258 | 8,373 | 8,734 | 9,633 | 9,558 |
| Operating expenses | 6,282 | 6,370 | 6,644 | 7,328 | 7,069 |
| Operating profit (EBITDA) | 1,976 | 2,003 | 2,090 | 2,305 | 2,490 |
| Other income | 116 | 117 | 122 | 135 | 68 |
| Depreciation | 191 | 194 | 202 | 223 | 228 |
| Interest | 94 | 95 | 99 | 109 | 99 |
| Profit before tax | 1,807 | 1,832 | 1,911 | 2,108 | 2,230 |
| Tax | 452 | 458 | 478 | 527 | 557 |
| Net profit | 1,355 | 1,374 | 1,433 | 1,581 | 1,672 |
| EPS (₹) | 5.44 | 5.52 | 5.76 | 6.35 | 6.72 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 12 periods. Premium unlocks the full 10-year history. See Premium